Time | Control | BM-MSCs |
---|
Low-dose | High-dose |
---|
Baseline | 79 (41, 94) | 75 (64, 107) | 60 (53, 84) |
6Â months | 78 (34, 107) | 70 (57, 126) | 53 (51, 90) |
12Â months | 83 (25, 95) | 90 (67, 140) | 53 (46, 82) |
12 months evolution | −0.5 (−16, 15) | 2.5 (−3, 25) | −4 (−22, 2) |
- The overall WORMS scores at baseline and 6 and 12Â months afterwards are presented as the median (IQR) of each group. The evolution within each treatment group at 12Â months is also presented, and was calculated by subtracting for each patient the values at 12Â months from the corresponding baseline values. Data are the median (IQR) of each group